Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuibin Lin

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|May 21, 2020
METTL1 limits differentiation and functioning of EPCs derived from human-induced pluripotent stem cells through a MAPK/ERK pathwayYujie Deng, Zhongyang Zhou, Shuibin Lin, et al.
Medcomm|June 25, 2026
RNA Modifications in Tumor Microenvironment: A New Dimension for Cancer TreatmentQiwen Li, Yating Sun, Shuibin Lin, et al.
Biochemical and Biophysical Research Communications|June 15, 2007
Clock controls timing of mouse pancreatic differentiation through regulation of Wnt- and Notch-based and cell division componentsZhixing Li, Lingjuan Ruan, Shuibin Lin, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|June 8, 2019
Nanovaccines for cancer immunotherapyYu Zhang, Shuibin Lin, Xiang-Yang Wang, et al.
Nature Protocols|October 18, 2019
Nucleotide resolution profiling of m<sup>7</sup>G tRNA modification by TRAC-SeqShuibin Lin, Qi Liu, Yi-Zhou Jiang, et al.
Bioactive Materials|March 8, 2023
Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapyTing Su, Xiang Liu, Shuibin Lin, et al.
Stem Cell Research & Therapy|July 24, 2020
METTL1-mediated m<sup>7</sup>G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular developmentYujie Deng, Zhongyang Zhou, Weidong Ji, et al.
Molecular Cell|April 28, 2016
The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer CellsShuibin Lin, Junho Choe, Peng Du, et al.
Advanced Therapeutics|August 2, 2021
pH-Responsive STING-Activating DNA Nanovaccines for Cancer ImmunotherapyYu Zhang, Tingting Shen, Shurong Zhou, et al.
ACS Applied Bio Materials|March 8, 2021
Nucleic Acid Immunotherapeutics for CancerTingting Shen, Yu Zhang, Shurong Zhou, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|May 21, 2020
METTL1 limits differentiation and functioning of EPCs derived from human-induced pluripotent stem cells through a MAPK/ERK pathwayYujie Deng, Zhongyang Zhou, Shuibin Lin, et al.
Medcomm|June 25, 2026
RNA Modifications in Tumor Microenvironment: A New Dimension for Cancer TreatmentQiwen Li, Yating Sun, Shuibin Lin, et al.
Biochemical and Biophysical Research Communications|June 15, 2007
Clock controls timing of mouse pancreatic differentiation through regulation of Wnt- and Notch-based and cell division componentsZhixing Li, Lingjuan Ruan, Shuibin Lin, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|June 8, 2019
Nanovaccines for cancer immunotherapyYu Zhang, Shuibin Lin, Xiang-Yang Wang, et al.
Nature Protocols|October 18, 2019
Nucleotide resolution profiling of m<sup>7</sup>G tRNA modification by TRAC-SeqShuibin Lin, Qi Liu, Yi-Zhou Jiang, et al.
Bioactive Materials|March 8, 2023
Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapyTing Su, Xiang Liu, Shuibin Lin, et al.
Stem Cell Research & Therapy|July 24, 2020
METTL1-mediated m<sup>7</sup>G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular developmentYujie Deng, Zhongyang Zhou, Weidong Ji, et al.
Molecular Cell|April 28, 2016
The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer CellsShuibin Lin, Junho Choe, Peng Du, et al.
Advanced Therapeutics|August 2, 2021
pH-Responsive STING-Activating DNA Nanovaccines for Cancer ImmunotherapyYu Zhang, Tingting Shen, Shurong Zhou, et al.
ACS Applied Bio Materials|March 8, 2021
Nucleic Acid Immunotherapeutics for CancerTingting Shen, Yu Zhang, Shurong Zhou, et al.
Pageof 10